Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (925) Arrow Down
Filter Results: (925) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (925)
    • People  (2)
    • News  (70)
    • Research  (778)
    • Events  (1)
    • Multimedia  (2)
  • Faculty Publications  (667)

Show Results For

  • All HBS Web  (925)
    • People  (2)
    • News  (70)
    • Research  (778)
    • Events  (1)
    • Multimedia  (2)
  • Faculty Publications  (667)
← Page 17 of 925 Results →

    Rosabeth M. Kanter

    Rosabeth Moss Kanter holds the Ernest L. Arbuckle Professorship at Harvard Business School, specializing in strategy, innovation, and leadership for change. Her strategic and practical insights guide leaders worldwide through teaching, writing, and direct... View Details

    Keywords: accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry; accounting industry
    • June 2003 (Revised March 2008)
    • Case

    Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene

    By: Regina E. Herzlinger and Marc Aquino
    Personalized medicine requires the identification of mutated genes. Schering-Plough's search for the one related to asthma requires finding families with the disease. Examines the industry that helps conduct such research, including contract research organizations. View Details
    Keywords: Health Disorders; Research and Development; Genetics; Biotechnology Industry; Biotechnology Industry
    Citation
    Educators
    Purchase
    Related
    Herzlinger, Regina E., and Marc Aquino. "Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene." Harvard Business School Case 303-044, June 2003. (Revised March 2008.)
    • October 2019
    • Supplement

    Impax Laboratories: Executing Accretive Transactions (A)

    By: Benjamin C. Esty and Daniel Fisher
    Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the... View Details
    Keywords: Financial Reporting; Financial Statements; Mergers and Acquisitions; Capital Structure; Financial Strategy; Competition; Competitive Advantage; Corporate Strategy; Pharmaceutical Industry; United States
    Citation
    Purchase
    Related
    Esty, Benjamin C., and Daniel Fisher. "Impax Laboratories: Executing Accretive Transactions (A)." Harvard Business School Spreadsheet Supplement 220-710, October 2019.
    • October 2019
    • Case

    Impax Laboratories: Executing Accretive Acquisitions (A)

    By: Benjamin C. Esty and Daniel Fisher
    Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the... View Details
    Keywords: Financial Reporting; Financial Statements; Mergers and Acquisitions; Capital Structure; Competition; Competitive Advantage; Corporate Strategy; Pharmaceutical Industry; United States
    Citation
    Educators
    Purchase
    Related
    Esty, Benjamin C., and Daniel Fisher. "Impax Laboratories: Executing Accretive Acquisitions (A)." Harvard Business School Case 220-030, October 2019.
    • January 1998 (Revised February 2006)
    • Background Note

    Creating Competitive Advantage

    By: Pankaj Ghemawat and Jan W. Rivkin
    A firm such as Schering-Plough that earns superior, long-run financial returns within its industry is said to enjoy a competitive advantage over its rivals. This note examines the logic of how firms create competitive advantage. It emphasizes two themes: First, to... View Details
    Keywords: Competitive Advantage; Competitive Strategy; Management; Business Strategy; Growth and Development Strategy; Innovation Strategy; Management Practices and Processes; Value Creation; Pharmaceutical Industry
    Citation
    Educators
    Purchase
    Related
    Ghemawat, Pankaj, and Jan W. Rivkin. "Creating Competitive Advantage." Harvard Business School Background Note 798-062, January 1998. (Revised February 2006.)
    • 07 Jan 2010
    • Working Paper Summaries

    International Differences in the Size and Roles of Corporate Headquarters: An Empirical Examination

    Keywords: by David Collis, David Young & Michael Goold

      Roberto Verganti

      Roberto Verganti (rverganti@hbs.edu) is in the Technology and Operations Management Unit at Harvard Business School. He teaches Design Theory and Practice for the View Details

      Keywords: industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods
      • June 2024 (Revised December 2024)
      • Case

      Lana Ghanem: Pushing the Boundaries of Health Care Through Venture Capital

      By: Joshua D. Margolis and Ahmed Dahawy
      Lana Ghanem, managing director of Hikma Ventures, the corporate venture arm of larger pharmaceutical group Hikma, is considering how to grow the venture arm as well as progress her own career. Over the past few years Hikma's executive team had been pressuring the... View Details
      Keywords: Business Divisions; Corporate Entrepreneurship; Investment; Corporate Governance; Health Care and Treatment; Leadership Development; Business or Company Management; Growth and Development Strategy; Business Strategy; Venture Capital; Personal Development and Career; Health Industry; Health Industry; Jordan
      Citation
      Educators
      Purchase
      Related
      Margolis, Joshua D., and Ahmed Dahawy. "Lana Ghanem: Pushing the Boundaries of Health Care Through Venture Capital." Harvard Business School Case 424-075, June 2024. (Revised December 2024.)
      • Web

      Strategy - Doctoral

      Strategy The doctoral program in Strategy encourages students to pursue multi-disciplinary research that utilizes multiple methodologies—quantitative, as well as qualitative—to study how companies and industries around the world develop... View Details
      • 07 Aug 2000
      • Research & Ideas

      The Business of Biotech

      coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details
      Keywords: by Julia Hanna; Biotechnology; Health; Technology
      • May 2021
      • Case

      The SMA Foundation: Steering Therapeutic Research and Development in a Rare Disease

      By: Amitabh Chandra, Spencer Lee-Rey and Caroline Marra
      This case explores incentives for rare disease drug development by chronicling the role of the Spinal Muscular Atrophy (SMA) Foundation in forming strategic partnerships with the scientific research community and pharmaceutical developers to transform the trajectory... View Details
      Keywords: Innovation and Invention; Strategy; Business or Company Management; Society; Health; Public Administration Industry; Public Administration Industry; United States
      Citation
      Educators
      Purchase
      Related
      Chandra, Amitabh, Spencer Lee-Rey, and Caroline Marra. "The SMA Foundation: Steering Therapeutic Research and Development in a Rare Disease." Harvard Business School Case 621-112, May 2021.
      • 14 Aug 2007
      • First Look

      First Look: August 14, 2007

      in West Africa, 1950-1970 Author:Stephanie Decker Periodical:Business History Review 81 (spring 2007): 59-86 Abstract Development, modernity, and industrialization became dominant themes in corporate advertising in Africa in the 1950s and... View Details
      Keywords: Martha Lagace
      • August 2023
      • Case

      Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company

      By: Satish Tadikonda and Brad Prosek
      Constellation Pharmaceuticals was a company focused on epigenetic therapies for cancer patients. Despite a promising start and an early deal with a leading biopharma company, the company weathered twin setbacks in the end of a major research collaboration and the... View Details
      Keywords: Mergers and Acquisitions; Health Care and Treatment; Organizational Change and Adaptation; Research and Development; Business Strategy; Partners and Partnerships; Goals and Objectives; Pharmaceutical Industry; United States
      Citation
      Educators
      Purchase
      Related
      Tadikonda, Satish, and Brad Prosek. "Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company." Harvard Business School Case 824-032, August 2023.
      • 16 Aug 2011
      • Working Paper Summaries

      Managing Political Risk in Global Business: Beiersdorf 1914-1990

      Keywords: by Geoffrey Jones & Christina Lubinski; Beauty & Cosmetics
      • January 2017
      • Case

      Danaher Corporation, 2007–2017

      By: John R. Wells and Gabriel Ellsworth
      On July 2, 2016, Danaher Corporation completed the spinoff of Fortive Corporation. The previous day, Danaher’s stock price had reached an all-time high. In 2015, Danaher had decided to split off its test and measurement, fuel and fleet management, and automation... View Details
      Keywords: Danaher; Fortive; Larry Culp; Beckman Coulter; Pall; Life Sciences; Diagnostics; Environmental Operations; Water Management; Dental; Testing; Measurement; Fuel; Fleet Management; Automation; Toolmaking; Tools; Disease Management; Continuous Improvement; Toyota Production System; Divestiture; Spinoffs; Spin-off; Networks; Acquisition; Mergers and Acquisitions; Business Conglomerates; Business Divisions; Business Subsidiaries; Business Units; Business Growth and Maturation; Business Model; For-Profit Firms; Joint Ventures; Restructuring; Engineering; Chemicals; Construction; Machinery and Machining; Profit; Revenue; Globalized Firms and Management; Multinational Firms and Management; Health; Health Care and Treatment; Health Disorders; Medical Specialties; Business History; Job Cuts and Outsourcing; Business or Company Management; Growth and Development Strategy; Management Analysis, Tools, and Techniques; Management Practices and Processes; Management Succession; Management Systems; Resource Allocation; Market Entry and Exit; Measurement and Metrics; Logistics; Business Processes; Organizational Change and Adaptation; Public Ownership; Problems and Challenges; Science; Genetics; Natural Environment; Wastes and Waste Processing; Science-Based Business; Opportunities; Strategy; Adaptation; Business Strategy; Competition; Competitive Strategy; Competitive Advantage; Consolidation; Corporate Strategy; Diversification; Expansion; Technology; Software; Technology Networks; Technology Platform; Value; Valuation; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; United States; District of Columbia
      Citation
      Educators
      Purchase
      Related
      Wells, John R., and Gabriel Ellsworth. "Danaher Corporation, 2007–2017." Harvard Business School Case 717-464, January 2017.
      • November 2017
      • Case

      The 'Wonder Drug' That Killed Babies

      By: Joshua Lev Krieger, Tom Nicholas and Matthew Preble
      In the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children... View Details
      Keywords: Regulation; Business and Government Relations; Business and Community Relations; Business and Stakeholder Relations; Product Marketing; Corporate Social Responsibility and Impact; Business History; Health; Government Legislation; Corporate Accountability; Ethics; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Pharmaceutical Industry; United States; United Kingdom; Australia; Germany; Europe
      Citation
      Educators
      Purchase
      Related
      Krieger, Joshua Lev, Tom Nicholas, and Matthew Preble. "The 'Wonder Drug' That Killed Babies." Harvard Business School Case 818-044, November 2017.
      • Web

      Hiring Organizations

      Partners AllWin Alpaca Real Estate Alphabroder Alpine Investors Alterra Capital Partners Altitude AI Altos Ventures Alumni Ventures Amazon Amazon Web Services - AWS Ambit Partners American Express American Industrial Partners Amex... View Details
      • 15 May 2007
      • First Look

      First Look: May 15, 2007

      the industry and dominated it for nearly 20 years, the well-respected company faces a bevy of new entrants from the banking, mortgage finance, and insurance sectors. In particular, management must decide how to respond to an aggressive... View Details
      Keywords: Martha Lagace
      • 23 Jul 2001
      • Research & Ideas

      How Relationships are Building Biotech

      How does an industry get born? To answer that question, it helps to turn the microscope on one fairly new industry: biotechnology. A still further way to get inside this question, according to HBS professor Monica C. Higgins, is to take a... View Details
      Keywords: by Martha Lagace & Mallory Stark

        Regina E. Herzlinger

        Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration at the Harvard Business School. She was the first woman to be tenured and chaired at Harvard Business School and serve on many established and start-up corporate health care/medical... View Details

        Keywords: insurance industry; insurance industry; insurance industry; insurance industry; insurance industry
        • ←
        • 17
        • 18
        • …
        • 46
        • 47
        • →
        ǁ
        Campus Map
        Harvard Business School
        Soldiers Field
        Boston, MA 02163
        →Map & Directions
        →More Contact Information
        • Make a Gift
        • Site Map
        • Jobs
        • Harvard University
        • Trademarks
        • Policies
        • Accessibility
        • Digital Accessibility
        Copyright © President & Fellows of Harvard College.